Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ritchie

Showing results (201-210 of 265) with videos related to

Pageof 27
Sort By:
British Journal of Pharmacology|September 4, 2019
Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insightsChen Huei Leo, Hooi Hooi Ng, Sarah A Marshall, et al.
International Journal of Molecular Sciences|February 23, 2020
The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic MiceSarah A Marshall, Cheng Xue Qin, Maria Jelinic, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 5, 2013
HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NOJennifer C Irvine, Nga Cao, Swati Gossain, et al.
Pharmacology & Therapeutics|October 28, 2025
Formylpeptide receptors: A novel target to treat cardiometabolic complicationsChen Huei Leo, Elizabeth A Vecchio, Ting Fu, et al.
British Journal of Pharmacology|April 24, 2023
Targeting G protein-coupled receptors for heart failure treatmentBui San Thai, Ling Yeong Chia, Anh T N Nguyen, et al.
British Journal of Pharmacology|August 29, 2012
Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26)Chengxue Qin, Keith D Buxton, Salvatore Pepe, et al.
Clinical Science (London, England : 1979)|December 2, 2022
Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discoveryLauren T May, Belinda A Bartolo, David G Harrison, et al.
Pharmacological Research|July 2, 2016
Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteriesNicola Kahlberg, Cheng Xue Qin, Jarryd Anthonisz, et al.
Nitric Oxide : Biology and Chemistry|September 10, 2013
The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsivenessR F Dautov, D T M Ngo, G Licari, et al.
Free Radical Biology & Medicine|May 5, 2015
Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signalingMiles J De Blasio, Karina Huynh, Chengxue Qin, et al.
Pageof 27

Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
British Journal of Pharmacology|September 4, 2019
Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insightsChen Huei Leo, Hooi Hooi Ng, Sarah A Marshall, et al.
International Journal of Molecular Sciences|February 23, 2020
The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic MiceSarah A Marshall, Cheng Xue Qin, Maria Jelinic, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 5, 2013
HNO/cGMP-dependent antihypertrophic actions of isopropylamine-NONOate in neonatal rat cardiomyocytes: potential therapeutic advantages of HNO over NOJennifer C Irvine, Nga Cao, Swati Gossain, et al.
Pharmacology & Therapeutics|October 28, 2025
Formylpeptide receptors: A novel target to treat cardiometabolic complicationsChen Huei Leo, Elizabeth A Vecchio, Ting Fu, et al.
British Journal of Pharmacology|April 24, 2023
Targeting G protein-coupled receptors for heart failure treatmentBui San Thai, Ling Yeong Chia, Anh T N Nguyen, et al.
British Journal of Pharmacology|August 29, 2012
Reperfusion-induced myocardial dysfunction is prevented by endogenous annexin-A1 and its N-terminal-derived peptide Ac-ANX-A1(2-26)Chengxue Qin, Keith D Buxton, Salvatore Pepe, et al.
Clinical Science (London, England : 1979)|December 2, 2022
Translating atherosclerosis research from bench to bedside: navigating the barriers for effective preclinical drug discoveryLauren T May, Belinda A Bartolo, David G Harrison, et al.
Pharmacological Research|July 2, 2016
Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteriesNicola Kahlberg, Cheng Xue Qin, Jarryd Anthonisz, et al.
Nitric Oxide : Biology and Chemistry|September 10, 2013
The nitric oxide redox sibling nitroxyl partially circumvents impairment of platelet nitric oxide responsivenessR F Dautov, D T M Ngo, G Licari, et al.
Free Radical Biology & Medicine|May 5, 2015
Therapeutic targeting of oxidative stress with coenzyme Q10 counteracts exaggerated diabetic cardiomyopathy in a mouse model of diabetes with diminished PI3K(p110α) signalingMiles J De Blasio, Karina Huynh, Chengxue Qin, et al.
Pageof 27